Iodixanol Injection 270 550 mg

Iodixanol Injection 270/550 mg is a radiopaque contrast medium used for imaging procedures. This solution is designed for intra-arterial administration and is manufactured by Fresenius Kabi Canada Ltd.

Iodixanol Injection 270/550 mg is primarily used as a contrast agent to enhance the visibility of internal structures during imaging procedures. It is commonly administered intra-arterially to improve the clarity of blood vessels and organs. This contrast medium is often utilized in diagnostic imaging to aid in the detection and evaluation of various conditions.

Iodixanol Injection 270/550 mg may cause common effects such as warmth or flushing at the injection site. Some individuals might experience temporary discomfort or mild allergic reactions. These effects are generally short-lived and subside quickly.

Iodixanol Injection 270/550 mg should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of adverse reactions. Patients with known allergies to contrast media should inform their healthcare provider before use.

Iodixanol Injection 270/550 mg may interact with certain medications or substances. It is advisable to consult a healthcare professional about potential interactions, especially with other contrast agents or medications that affect kidney function.